Jeong Jae Hoon, Cho Sehyung, Pak Youngmi Kim
Department of Physiology, Kyung Hee University College of MedicineSeoul 130-701, Korea.
Exp Mol Med. 2009 Jun 30;41(6):406-16. doi: 10.3858/emm.2009.41.6.046.
Peroxisome proliferator activated receptor (PPAR) gamma coactivator-1alpha (PGC-1alpha) may be implicated in cholesterol metabolism since PGC-1alpha co-activates estrogen receptor alpha (ERalpha) transactivity and estrogen/ERalpha induces the transcription of LDL receptor (LDLR). Here, we show that overexpression of PGC-1alpha in HepG2 cells represses the gene expression of LDLR and does not affect the ERalpha-induced LDLR expression. PGC-1alpha suppressed the LDLR promoter-luciferase (pLR1563- luc) activity regardless of cholesterol or functional sterol-regulatory element-1. Serial deletions of the LDLR promoter revealed that the inhibition by PGC-1alpha required the LDLR promoter regions between -650 bp and -974 bp. Phosphorylation of PGC-1alpha may not affect the suppression of LDLR expression because treatment of SB202190, a p38 MAP kinase inhibitor, did not reverse the LDLR down-regulation by PGC-1alpha. This may be the first report showing the repressive function of PGC-1alpha on gene expression. PGC-1alpha might be a novel modulator of LDLR gene expression in a sterol-independent manner, and implicated in atherogenesis.
过氧化物酶体增殖物激活受体(PPAR)γ共激活因子-1α(PGC-1α)可能参与胆固醇代谢,因为PGC-1α可共激活雌激素受体α(ERα)的转录活性,且雌激素/ERα可诱导低密度脂蛋白受体(LDLR)的转录。在此,我们发现PGC-1α在HepG2细胞中的过表达会抑制LDLR的基因表达,且不影响ERα诱导的LDLR表达。无论胆固醇或功能性固醇调节元件-1如何,PGC-1α均会抑制LDLR启动子-荧光素酶(pLR1563-luc)活性。对LDLR启动子进行系列缺失分析表明,PGC-1α的抑制作用需要LDLR启动子-650 bp至-974 bp之间的区域。PGC-1α的磷酸化可能不会影响对LDLR表达的抑制,因为p38丝裂原活化蛋白激酶抑制剂SB202190的处理并未逆转PGC-1α对LDLR的下调作用。这可能是首篇报道PGC-1α对基因表达具有抑制功能的文章。PGC-1α可能是以一种不依赖固醇的方式成为LDLR基因表达的新型调节因子,并与动脉粥样硬化的发生有关。